Tenaya Therapeutics to Present Preclinical Data on Its Gene Therapy Programs at the ESGCT 28th Annua

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Tenaya Therapeutics, Inc. (NASDAQ:TNYA), a biotechnology company with a mission to discover, develop and deliver curative therapies that address the underlying causes of heart disease, announced today that it will present new preclinical data at the virtual 28th Annual C...

Related Keywords

United States ,Leone Patterson ,Wendy Ryan ,Laura Lombardi ,European Society Of Gene ,Nasdaq ,Gene Transfer Prevents Development Of Arrhythmogenic Cardiomyopathy ,Tenaya Therapeutics Inc ,Exchange Commission ,University Of Texas Southwestern Medical Center ,Securities Exchange ,Tenaya Therapeutics ,Annual Congress ,European Society ,Cell Therapy ,Premature Lethality ,Cardiac Hypertrophy ,Associate Director ,Gene Therapy Biology ,Transfer Prevents Development ,Arrhythmogenic Cardiomyopathy ,Gladstone Institutes ,Texas Southwestern Medical Center ,Gene Therapy ,Cellular Regeneration ,Securities Act ,Securities Exchange Act ,